PEAK6 Investments’s Anterix ATEX Stock Holding History

PEAK6 Investments’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100	Closed	-$4K	–	4822
2020 Q4	$4K	Buy	+100	New	+$3.3K	﹤0.01%	4447
2020 Q3	–	Sell	-15,100	Closed	-$685K	–	4340
2020 Q2	$685K	Buy	+15,100	New	+$772K	﹤0.01%	2419

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCC

Bain Capital Credit Boston, Massachusetts $303M AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

PEAK6 Investments's ATEX Position: Q3 2020 in Review

PEAK6 Investments sold out of Anterix (ATEX) in Q3 2020, closing a stake of 5,962 shares — an estimated $252K sold.

PEAK6 Investments first reported a position in ATEX in Q2 2020 and held it in 1 quarter. The position peaked at $270K in Q2 2020. 96 funds tracked by Wall St. Rank hold ATEX as of Q3 2020.

PEAK6 Investments reported no remaining Anterix position as of Q3 2020 after selling out during the quarter.
PEAK6 Investments sold 5,962 Anterix shares in Q3 2020, an estimated $252K.
PEAK6 Investments first reported a position in Anterix in Q2 2020 and held it in 1 quarter.
PEAK6 Investments's Anterix position peaked at $270K in Q2 2020.
96 funds tracked by Wall St. Rank held Anterix as of Q3 2020.

Based on PEAK6 Investments's 13F filing for Q3 2020, filed 13 Nov 2020.